-
Product Insights
NewDiamiR LLC Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our DiamiR LLC Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. DiamiR LLC (DiamiR) is a medical device company. The company is involved in the development and commercialization of technology based on analysis of brain-enriched microRNA biomarkers in blood plasma to be used for screening, early and differential diagnosis. It offers microRNAs that are a class of small non-coding regulatory RNA molecules, which modulate target gene expression and protein production. DiamiR...
-
Product Insights
NewQuarterly Savory Biscuits pricing trends in the United Arab Emirates
Empower your strategies with our Quarterly Savory Biscuits pricing trends in the United Arab Emirates report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and...
-
Product Insights
NewMiromatrix Medical Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Miromatrix Medical Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Miromatrix Medical Inc (Miromatrix Medical) is a biotechnology company that focuses on the development of transplantable human organs. It offers modern, a porcine liver-derived acellular biologic wound matrix indicated for wound management; and miromesh, a biological mesh extracted from perfusion decellularized porcine liver for soft tissue repair and reinforcement. The company is investigating programs to bioengineer transplantable liver for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Empasiprubart in Delayed Graft Function (DGF)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Empasiprubart in Delayed Graft Function (DGF) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Empasiprubart in Delayed Graft Function (DGF) Drug Details: ARGX-117...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Empasiprubart in Dermatomyositis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Empasiprubart in Dermatomyositis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Empasiprubart in Dermatomyositis Drug Details: ARGX-117 (PRO-02) is under development for the...
-
Product Insights
NewQuarterly Condiment Sauces pricing trends in the United Arab Emirates
Empower your strategies with our Quarterly Condiment Sauces pricing trends in the United Arab Emirates report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and...
-
Product Insights
NewQuarterly Wet Cooking Sauces pricing trends in the United Kingdom
Empower your strategies with our Quarterly Wet Cooking Sauces pricing trends in the United Kingdom report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dilanubicel in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dilanubicel in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dilanubicel in Acute Lymphocytic Leukemia (ALL,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dilanubicel in Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dilanubicel in Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dilanubicel in Chronic Myelocytic Leukemia (CML,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Olvimulogene Nanivacirepvec in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Olvimulogene Nanivacirepvec in Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Olvimulogene Nanivacirepvec in Ovarian Cancer Drug Details: Olvimulogene nanivacirepvec (GL-ONC1)...